New Osteoarthritis Treatment Has to Wait Even Longer for FDA Approval

Health and Healthcare

Published: October 14, 2019 10:00 am

Last Updated: January 6, 2020 2:02 am

Flexion Therapeutics Inc. (NASDAQ: FLXN) has announced that the U.S. Food and Drug Administration (FDA) informed the company that it needs additional time to complete the review of the supplemental New Drug Application (sNDA) for Zilretta.

Note that the anticipated Prescription Drug User Fee Act (PDUFA) action date was today, October 14, 2019.

Although the FDA did not provide a new action date, the FDA informed the company that the review is expected to be completed in the coming weeks. The FDA has not asked for any additional clinical data, and the company has provided the FDA with all information requested to date.

In December 2018, the company filed the sNDA seeking to revise the Zilretta product label based on results from an open-label Phase 3b clinical trial, which evaluated repeat administration of Zilretta in patients with osteoarthritis knee pain.

The approval of Zilretta was based on the pivotal Phase 3 trial that demonstrated that this steroid significantly reduced knee pain for 12 weeks, with some people experiencing pain relief through week 16.

Shares of Flexion traded down about 5% in Monday’s premarket but were last seen up fractionally at $13.46, in a 52-week range of $8.76 to $19.82. The consensus price target is $25.78.

24/7 Wall St.
Jefferies Top Growth Stock Picks Have Huge Upside and Earnings Potential

The Average American Has No Idea How Much Money You Can Make Today ^(Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

¹https://www.fdic.gov/national-rates-and-rate-caps